ArticleMelanoma research2020

Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients.

Jesus Vera Aguilera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.